title: Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition).
abstract: Diagnostic guidelines for Kawasaki Disease was revised to meet the present situation in 2002. This issue intends to explain new guidelines and their backgrounds. Major alterations are interpretation of cases with 4 or fewer febrile days shortened by early intravenous immunoglobulin treatment, and the clinical importance of atypical (incomplete, or suspected) cases.
authors.affiliation: Department of Pediatrics, Nihon University School of Medicine, Tokyo 173-8610, Japan. maysw@med.nihon-u.ac.jp
authors.forename: Mamoru
authors.initials: M
authors.lastname: Ayusawa
authors.forename: Tomoyoshi
authors.initials: T
authors.lastname: Sonobe
authors.forename: Shigeru
authors.initials: S
authors.lastname: Uemura
authors.forename: Shunnichi
authors.initials: S
authors.lastname: Ogawa
authors.forename: Yoshikazu
authors.initials: Y
authors.lastname: Nakamura
authors.forename: Nobuyuki
authors.initials: N
authors.lastname: Kiyosawa
authors.forename: Masahiro
authors.initials: M
authors.lastname: Ishii
authors.forename: Kensuke
authors.initials: K
authors.lastname: Harada
mesh_terms: D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D009080:Mucocutaneous Lymph Node Syndrome / Q000175:diagnosis* / Q000188:drug therapy
chemical_list: D016756:Immunoglobulins, Intravenous